BOMP/EPI intensive alternating chemotherapy for IGCCC poor-prognosis germ-cell tumors: The Spanish Germ-Cell Cancer Group experience (GG)

This publication has 16 references indexed in Scilit:

• Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group
  British Journal of Cancer, 1998
• Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study.
  Journal of Clinical Oncology, 1998
• Testicular Germ-Cell Cancer
  New England Journal of Medicine, 1997
• International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group.
  Journal of Clinical Oncology, 1997
• A Phase II Trial of VP-16, Ifosfamide, Cisplatin, Vinblastine, and Bleomycin in Advanced Germ-Cell Tumors
  American Journal of Clinical Oncology, 1996
• Mortality in Testicular Cancer: 10 Years’ Experience at a Single Centre
  Urologia Internationalis, 1996
• Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol.
  Journal of Clinical Oncology, 1991
• Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol.
  Journal of Clinical Oncology, 1989
• Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or Etoposide
  New England Journal of Medicine, 1987
• Tumour-marker levels and prognosis in malignant teratoma of the testis
  British Journal of Cancer, 1980